While the incidence of prostate cancer is greater in older men, the screening guidelines are murky. A new study analyzed what happened after older men were screened. 

The statistics are pretty clear that most American men are not going to die of prostate cancer. But the question remains: who should be screened and how often? A new crystal ball may be on the horizon.

Selenium is a trace mineral that helps prevent cell damage. Studies regarding this mineral have been inconclusive. But new research suggests selenium may have anti-cancer properties.

If you’re a man – or a woman for that matter – you’re probably confused about cancer screenings. The recommendations for prostate cancer screenings have been all over the place.

Men with advanced prostate cancer usually take medicines to keep the disease at bay. These medications block male hormones that feed the cancer. New research evaluated the best way to take these medications.

Lynch syndrome is the most common genetic condition that’s linked to cancer.  While it is fairly rare, the condition can raise the risk for various cancers. But the connection between Lynch syndrome and prostate cancer has been uncertain.

Baldness affects about 60 percent of men at some time in their lives.  Researchers now think baldness and prostate cancer may be linked in African American men.

Many cancer patients take medications to prevent the disease from returning or spreading. One medication designed to prevent cancer from spreading to the bones fell short in a recent study.

The guidelines for screening and treating prostate cancer have become confusing. A man’s race may now become a consideration before treatment begins or is delayed.

Latino men don’t get the prostate cancer care they need for a variety of reasons, and it’s not just about the cost. A new study has summarized those barriers.